Biotherapeutic Department Of Chinsese PLA Gereral Hospital

Who we are

  • January 1, 1970
    GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.